Revvity, Inc. (FRA:PKN)

Market Cap	9.97B
Revenue (ttm)	2.41B
Net Income (ttm)	203.09M
Shares Out	n/a
EPS (ttm)	1.70
PE Ratio	49.09
Forward PE	19.31
Dividend	0.25 (0.29%)
Ex-Dividend Date	Oct 17, 2025

Volume	n/a
Average Volume	17
Open	87.72
Previous Close	90.08
Day's Range	85.28 - 87.72
52-Week Range	69.68 - 121.05
Beta	n/a
RSI	53.61
Earnings Date	Jan 29, 2026

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services. The company provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services; and instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and dise...

• Industry: Laboratory Analytical Instruments
• Founded: 1937
• Employees: 11,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PKN

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Financial numbers in USD